911 results on '"Gunn, Roger N"'
Search Results
2. Estimation of target occupancy in repeated dosing design studies using positron emission tomography: Biases due to target upregulation
3. PET Parametric Imaging: Past, Present, and Future
4. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge
5. Principles of PET and Its Role in Understanding Drug Delivery to the Brain
6. Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [11C]PHNO PET
7. Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals
8. Principles of PET and Its Role in Understanding Drug Delivery to the Brain
9. The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease
10. The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study
11. Estimating Braak stage from [18F]MK6240 PET scans
12. Estimation of target occupancy in repeated dosing design studies using positron emission tomography: Biases due to target upregulation
13. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
14. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals
15. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats
16. Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge
17. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
18. Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region
19. Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
20. Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challenge
21. Disease-related patterns of in vivo pathology in Corticobasal syndrome
22. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of Synaptic Vesicle Glycoprotein 2A
23. Imaging in Central Nervous System Drug Discovery
24. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
25. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper
26. Synaptic terminal density early in the course of schizophrenia: an in vivo UCB-J positron emission tomographic imaging study of synaptic vesicle glycoprotein 2A (SV2a)
27. A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
28. Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation
29. Principles of PET and Its Role in Understanding Drug Delivery to the Brain
30. Imaging Type 1 Glycine Transporters in the CNS Using Positron Emission Tomography
31. Building a database for brain 18 kDa translocator protein imaged using [11C]PBR28 in healthy subjects
32. Quantification of human brain PDE4 occupancy by GSK356278: A [11C](R)-rolipram PET study
33. PROGRESS IN DEVELOPING A LIGHT‐STABLE 4R TAU PET IMAGING AGENT: APN‐1701 FIH
34. In Vivo Head‐To‐Head Comparison of [ 18 F]GTP1 and [ 18 F]PI2620 in Alzheimer’s Disease
35. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain
36. A Generalised Spatio-Temporal Registration Framework for Dynamic PET Data: Application to Neuroreceptor Imaging
37. Spatial-temporal Pharmacokinetic Model Based Registration of 4D Brain PET Data
38. Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity
39. Neurons derived from individual early Alzheimer’s disease patients reflect their clinical vulnerability
40. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge
41. A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18-F MK-6240 Positron Emission Tomography
42. Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with 11C-BU99008 PET
43. Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease
44. 11C-DPA-713 has much greater specific binding to translocator protein 18 kDa (TSPO) in human brain than 11C-(R)-PK11195
45. Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration
46. Evidence for GABA‐A receptor dysregulation in gambling disorder: correlation with impulsivity
47. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis
48. First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site
49. Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
50. Impact of image-based motion correction on dopamine D3/D2 receptor occupancy—comparison of groupwise and frame-by-frame registration approaches
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.